Across America, bills for Covid-19 treatment are coming due, and some patients are paying large out-of-pocket fees despite a federal safety net set up to help them avoid such financial surprises.
Gilead Sciences Inc will acquire biotech company Immunomedics Inc for $21 billion, a move that will strengthen its cancer portfolio by gaining access to a promising drug, the two companies said in a joint statement on Sunday.
The Texas Academy of Family Physicians is also asking legislators to expand Medicaid insurance coverage to low-income adults and restore funding for a program that studied racial health disparities.
In America's four largest cities, at least half of people say they have experienced the loss of a job or a reduction in wages or work hours in their household since the start of the coronavirus outbreak. That's the finding of a new poll published Wednesday by NPR, the Robert Wood Johnson Foundation and the Harvard T.H. Chan School of Public Health.
The collective compensation for the highest paid hospital leaders in Massachusetts rose 95% over five years, with 12 of the executives reporting compensation over $2 million in the most recently available year.
In the United States, healthcare providers are typically paid based on services provided. The more tests a patient undergoes, the bigger the bill. Vivian Lee, a radiologist and healthcare executive, says this fee-for-service business model needs to be reconsidered.